6 | Antidepressive Agents (Antidepressants)IBA
01/2023
-
04/2003 |
6 | KNT 127IBA
01/2023
-
01/2017 |
6 | Capsaicin (Zostrix)FDA Link
01/2022
-
04/2003 |
5 | delta Opioid Receptors (delta Opioid Receptor)IBA
12/2023
-
09/2008 |
4 | RiluzoleFDA LinkGeneric
10/2015
-
01/2011 |
4 | Antitussive Agents (Antitussives)FDA Link
09/2008
-
04/2003 |
3 | Oxycodone (Oxycontin)FDA LinkGeneric
10/2022
-
11/2005 |
3 | Anti-Anxiety Agents (Anxiolytics)IBA
01/2022
-
01/2013 |
3 | Streptozocin (Streptozotocin)FDA Link
04/2006
-
11/2005 |
2 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2023
-
04/2014 |
2 | Oxytocin (Pitocin)FDA LinkGeneric
10/2023
-
12/2022 |
2 | AcidsIBA
01/2021
-
12/2005 |
2 | 4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA
01/2021
-
04/2018 |
2 | Vincristine (Oncovin)FDA LinkGeneric
04/2006
-
09/2005 |
2 | Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2006
-
09/2005 |
2 | Mexiletine (Mexitil)FDA LinkGeneric
04/2006
-
11/2004 |
1 | AnkyrinsIBA
10/2023 |
1 | Amyloidogenic ProteinsIBA
10/2023 |
1 | Morphine (MS Contin)FDA LinkGeneric
10/2022 |
1 | TapentadolFDA Link
10/2022 |
1 | Opioid Analgesics (Opioids)IBA
10/2022 |
1 | TabletsIBA
10/2022 |
1 | Alanine (L-Alanine)FDA Link
03/2022 |
1 | Sulfhydryl Compounds (Thiols)IBA
03/2022 |
1 | Glutathione (Reduced Glutathione)IBA
03/2022 |
1 | Acetylcysteine (Siran)FDA LinkGeneric
03/2022 |
1 | Disulfiram (Antabuse)FDA Link
01/2022 |
1 | Aminobutyrates (Aminobutyric Acid)IBA
01/2022 |
1 | BenzodiazepinesIBA
01/2022 |
1 | Charcoal (Charbon)IBA
01/2022 |
1 | Diazepam (Valium)FDA LinkGeneric
01/2022 |
1 | alphaxalone (alfaxalone)IBA
01/2022 |
1 | GABA-A Receptors (GABA(A) Receptor)IBA
01/2022 |
1 | alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2021 |
1 | Glutamic Acid (Glutamate)FDA Link
01/2021 |
1 | 6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)IBA
01/2021 |
1 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2020 |
1 | 4-hydroxyphenylethanolIBA
01/2019 |
1 | Amyloid (Amyloid Fibrils)IBA
01/2019 |
1 | Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2017 |
1 | Therapeutic UsesIBA
01/2017 |
1 | Sertraline (Zoloft)FDA LinkGeneric
03/2015 |
1 | Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
04/2013 |
1 | Glucagon (Glukagon)FDA Link
04/2013 |
1 | Adrenocorticotropic Hormone (ACTH)FDA Link
04/2013 |
1 | MorphinansIBA
09/2008 |
1 | methanesulfonic acid (methanesulfonate)IBA
09/2008 |
1 | NG-Nitroarginine Methyl Ester (L-NAME)IBA
04/2006 |
1 | Tetrodotoxin (Tetradotoxin)IBA
04/2006 |
1 | Sodium Channels (Sodium Channel)IBA
04/2006 |
1 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
03/2006 |
1 | Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
03/2006 |
1 | AminesIBA
03/2006 |
1 | LigandsIBA
03/2006 |
1 | AerosolsIBA
03/2006 |
1 | TRPV1 receptorIBA
03/2006 |
1 | N- (2- methyl- 3- hydroxyphenyl)- 5,8,11,14- eicosatetraenamideIBA
03/2006 |
1 | SolutionsIBA
03/2006 |
1 | AM 251 (AM251)IBA
03/2006 |
1 | anandamide (arachidonylethanolamide)IBA
03/2006 |
1 | capsazepineIBA
03/2006 |
1 | Membrane Transport Proteins (Biological Pump)IBA
03/2006 |
1 | CannabinoidsIBA
03/2006 |
1 | Cibacron Blue F 3GAIBA
12/2005 |
1 | Purinergic Receptors (Receptors, Purine)IBA
12/2005 |
1 | Adenosine Triphosphate (ATP)IBA
12/2005 |
1 | Irritants (Vesicants)IBA
12/2005 |
1 | pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidIBA
12/2005 |
1 | 2',3'-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphateIBA
12/2005 |